*:Co-first author; #:Co-corresponding author
1. Fu Z*, Li S*, Xue J*, Li Q, Jiang T, Wu L, Wang L, Zhang H, Geng X, Guo X, Yan X, You H, Zhang L, Zhang Y, Song T, Wu Y, Yu X, Hou Y#, Luo D#. A potential therapeutic target at Connexin 43 serine phosphorylation against ischaemia/reperfusion arrhythmia, Br J Pharmacol,2025, Epub ahead of print. DOI: 10.1111/bph.70090.
2.Xue JY, Wang Z, Shinagawa S, Ohashi H, Otomo N, Elcioglu NH, Nakashima T, Nishimura G, Ikegawa S#, Guo L#. TNFRSF11A-Associated Dysosteosclerosis: A Report of the Second Case and Characterization of the Phenotypic Spectrum, J Bone Miner Res, 2019,34,1873-1879. DOI: 10.1002/jbmr.3805.
3. Xue JY, Grigelioniene G, Wang Z, Nishimura G, Iida A, Matsumoto N, Tham E, Miyake N, Ikegawa S#, Guo L#. SLC4A2 Deficiency Causes a New Type of Osteopetrosis, J Bone Miner Res, 2022,37,226-235. DOI: 10.1002/jbmr.4462.